Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Andrew J. Dowson"'
Autor:
Astrid Gendolla, Charly Gaul, Axel Heinze, Keyoumars Ashkan, Giannis Sokratous, Theresa Wodehouse, Hartmut Göbel, Andrew J. Dowson, Vivek Mehta
Publikováno v:
Acta neurochirurgica. 162(12)
Migraine is common and ranked as the first cause of disability in people under fifty. Despite significant advances in its pharmacological treatment, it often remains intractable. Neuromodulation is one option considered in the management of those pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c82929571454d5aa20ed76540cc86d9
https://pubmed.ncbi.nlm.nih.gov/32377948
https://pubmed.ncbi.nlm.nih.gov/32377948
Autor:
Linda M. Jenkins, Lucy V Clark, Paul T. Seed, Leone Ridsdale, Laurence Goldstein, Andrew J. Dowson
Publikováno v:
Psychology & Health. 26:751-764
Headache is the most common neurological symptom presenting to general practitioners (GPs). Identifying factors predicting outcome in patients consulting their GPs for headache may help GPs with prognosis and choose management strategies which would
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20d3ad6411769fab35ef8ec814b805d8
https://doi.org/10.1080/08870446.2010.493217
https://doi.org/10.1080/08870446.2010.493217
Publikováno v:
The Journal of Headache and Pain
A questionnaire (Migraine Questionnaire; MQ) was developed to help pharmacists identify consumers with migraine suitable for non-prescription treatment with a triptan. Adults, who knew or thought that they had migraine, participated in three, sequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef082e28364f5f430c4f6caeeaa14cf
https://doi.org/10.1007/s10194-008-0070-6
https://doi.org/10.1007/s10194-008-0070-6
Publikováno v:
Pharmaceutical Medicine. 22:165-174
Background: The Short Pain Inventory (SPI©) is a prospective, validated questionnaire that assesses pain severity and mood disturbances for a variety of conditions. Objectives: In this prospective, within-group, comparative study, the SPI® was used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb3d151753e4813df7add9ef330ffdf7
https://doi.org/10.1007/bf03256698
https://doi.org/10.1007/bf03256698
Autor:
Joseph V. De Giovanni, Richard Peatfield, Andrew J. Dowson, Arif Anis Khan, Michael J. Mullen, Trevor Rees, W. Stewart Hillis, W. Lindsay Morrison, Iqbal S. Malik, Christopher Wells, Giles Elrington, Susan Lipscombe, David Hildick-Smith, Keith W. Muir, Anthony Rickards
Publikováno v:
Circulation. 117:1397-1404
Background— Patent foramen ovale (PFO) is prevalent in patients with migraine with aura. Observational studies show that PFO closure resulted in migraine cessation or improvement in ≈80% of such patients. We investigated the effects of PFO closur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ecf2e01dd0bac692620f9a4a964545
https://doi.org/10.1161/circulationaha.107.727271
https://doi.org/10.1161/circulationaha.107.727271
Publikováno v:
Journal of Clinical Nursing. 16:159-167
Aims and objectives. The aim of this paper is to outline the classifications of migraine and chronic daily headaches (i.e. headaches occurring at more than 15 days per month) and briefly describe their epidemiology and management. After outlining the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60f73ce91b090a55c753009636cecc7
https://doi.org/10.1111/j.1365-2702.2006.01562.x
https://doi.org/10.1111/j.1365-2702.2006.01562.x
Publikováno v:
Primary Health Care. 17:25-28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22b09a1e62957244fd9bfb05cc6fcd85
https://doi.org/10.7748/phc2007.03.17.2.25.c4390
https://doi.org/10.7748/phc2007.03.17.2.25.c4390
Autor:
Peter J. Goadsby, Andrew J. Dowson, Julio Pascual, Carl Dahlöf, Markus Färkkilä, Luís Cunha, G. C. Manzoni, Valentín Mateos, Hans-Christoph Diener, Hélène Massiou, I. Raets
Publikováno v:
Acta Neurologica Scandinavica. 115:34-40
Objective: To compare almotriptan and zolmitriptan in the treatment of acute migraine. Methods: This multicentre, double-blind trial randomized adult migraineurs to almotriptan 12.5 mg (n = 532) or zolmitriptan 2.5 mg (n = 530) for the treatment of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b5ee1d0db243cc10eff6d662967334
https://doi.org/10.1111/j.1600-0404.2006.00739.x
https://doi.org/10.1111/j.1600-0404.2006.00739.x
Publikováno v:
Primary Health Care. 16:25-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71f52801b6ed00c2edd98330c3f9a059
https://doi.org/10.7748/phc.16.9.25.s26
https://doi.org/10.7748/phc.16.9.25.s26